Study of A-101 Topical Solution for the Treatment of Common Warts
NCT03687372
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
503
Enrollment
INDUSTRY
Sponsor class
Conditions
Common Wart
Interventions
DRUG:
A-101
OTHER:
vehicle
Sponsor
Aclaris Therapeutics, Inc.